Serving leading biopharmaceutical companies globally:

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Brodalumab - Biologic Drug Details

See Plans and Pricing

« Back to Dashboard

Summary for brodalumab

Tradenames:	1
Patents:	7
Applicants:	1
BLAs:	1
Suppliers: see list	1

Pharmacology for brodalumab

Ingredient-type	Antibodies, Monoclonal
Mechanism of Action	Interleukin 17 Receptor A Antagonists

US Patents for brodalumab

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Valeant Luxembourg	SILIQ	brodalumab	INJECTABLE;INJECTION	761032	001	2017-02-15	Start Trial	InCube Labs, LLC (San Jose, CA)	2034-05-15	RX		search
Valeant Luxembourg	SILIQ	brodalumab	INJECTABLE;INJECTION	761032	001	2017-02-15	Start Trial	CureVac AG (Tubingen, DE)	2032-02-15	RX		search
Valeant Luxembourg	SILIQ	brodalumab	INJECTABLE;INJECTION	761032	001	2017-02-15	Start Trial	THERASYN SENSORS, INC. (Eggertsville, NY)	2033-03-14	RX		search
Valeant Luxembourg	SILIQ	brodalumab	INJECTABLE;INJECTION	761032	001	2017-02-15	Start Trial	City of Hope (Duarte, CA)	2030-10-08	RX		search
Valeant Luxembourg	SILIQ	brodalumab	INJECTABLE;INJECTION	761032	001	2017-02-15	Start Trial	CureVac AG (Tubingen, DE)	2032-02-15	RX		search
Valeant Luxembourg	SILIQ	brodalumab	INJECTABLE;INJECTION	761032	001	2017-02-15	Start Trial	Pfizer Inc. (New York, NY)	2036-10-05	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for brodalumab

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
European Patent Office	3288543	Start Trial
Australia	2014236559	Start Trial
South Korea	102005562	Start Trial
South Korea	20140082794	Start Trial
Japan	2013541542	Start Trial
Japan	6357111	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Express Scripts

AstraZeneca

Medtronic

Merck

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.